Helen E Scharfman Selected Research

Helen E Scharfman Research Topics

Disease

31	Seizures (Absence Seizure) 01/2022 - 04/2002
21	Epilepsy (Aura) 01/2020 - 09/2004
12	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 04/2002
7	Temporal Lobe Epilepsy 01/2022 - 09/2002
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2005
3	Nervous System Diseases (Neurological Disorders) 11/2017 - 12/2006
2	Cognitive Dysfunction 01/2021 - 08/2012
2	Edema (Dropsy) 06/2010 - 01/2004
2	Mental Disorders (Mental Disorder) 12/2006 - 02/2005
1	Angelman Syndrome (Syndrome, Angelman) 01/2021
1	Brain Injuries (Brain Injury) 01/2019
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 12/2013
1	Schizophrenia (Dementia Praecox) 08/2012
1	Neurodevelopmental Disorders 03/2012
1	Hypothyroidism 03/2012
1	Contusions 06/2010
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2010
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2008
1	Body Weight (Weight, Body) 12/2008
1	Migraine Disorders (Migraine) 07/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2004
1	Chronic Pain 09/2004
1	Inflammation (Inflammations) 01/2004
1	Brain Ischemia (Cerebral Ischemia) 01/2004

Drug/Important Bio-Agent (IBA)

15	Pilocarpine (Ocusert)FDA LinkGeneric 01/2020 - 04/2002
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2013 - 04/2002
6	Estrogens (Estrogen)FDA Link 09/2010 - 02/2005
5	Anticonvulsants (Antiepileptic Drugs)IBA 02/2015 - 12/2008
4	Kainic Acid (Kainate)IBA 01/2022 - 09/2002
4	Amyloid (Amyloid Fibrils)IBA 01/2020 - 09/2012
4	ConvulsantsIBA 01/2019 - 04/2002
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
3	Gonadal HormonesIBA 07/2015 - 09/2006
3	Hormones (Hormone)IBA 09/2010 - 09/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008 - 01/2004
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2017
2	SteroidsIBA 12/2014 - 09/2006
2	Nerve Growth Factors (Neurotrophins)IBA 01/2013 - 03/2012
2	Testosterone (Sustanon)FDA Link 09/2010 - 12/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2008 - 01/2004
2	Neuropeptide YIBA 07/2008 - 01/2006
2	Progesterone FDA LinkGeneric 09/2006 - 11/2005
1	Atropine FDA LinkGeneric 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	CationsIBA 01/2021
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2021
1	LigandsIBA 01/2021
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2020
1	ChromatinIBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Calcium-Binding ProteinsIBA 11/2017
1	Calbindin 1IBA 11/2017
1	CalbindinsIBA 11/2017
1	Histones (Histone)IBA 11/2017
1	Ethosuximide (Zarontin)FDA LinkGeneric 02/2015
1	gamma-Aminobutyric Acid (GABA)IBA 01/2014
1	Peptides (Polypeptides)IBA 09/2012
1	Peptide Hydrolases (Proteases)FDA Link 09/2012
1	Sodium Channels (Sodium Channel)IBA 09/2012
1	Thyroid HormonesIBA 03/2012
1	PotassiumIBA 11/2011
1	Aquaporins (Water Channels)IBA 06/2010
1	Cholinergic Agents (Cholinergics)IBA 09/2009
1	Diazepam (Valium)FDA LinkGeneric 12/2008
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2008
1	GlycogenIBA 07/2007
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 07/2007
1	4-chlorokynurenineIBA 07/2005
1	ProdrugsIBA 09/2002
1	AlbuminsIBA 04/2002

Therapy/Procedure

3	Therapeutics 11/2017 - 08/2009
1	Subcutaneous Injections 01/2021
1	Cognitive Training 08/2012